|
|
|
|
 |
 |
|
|
 |
 |
|
FUZEON® is the first in a class of anti-HIV drugs called fusion inhibitors. FUZEON is different from existing antiviral treatments because it works outside of T cells (CD4) to help prevent HIV from infecting the cells in the first place.
Fuzeon.com is your resource for learning more about FUZEON and how to get help with your treatment. Through FUZEON Connections, you'll be connected with a diverse information and support network that is committed to helping you succeed with FUZEON — every step of the way.
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
THIS SITE INTENDED FOR U.S. AUDIENCES ONLY.
For more information about FUZEON contact your physician or other healthcare professional. FUZEON is a registered trademark of Roche Laboratories Inc. and Trimeris, Inc. ©2003-2007 Roche Laboratories Inc. and Trimeris, Inc. All rights reserved. Use and access to this site subject to the terms and conditions as set out in our health disclaimer and privacy policy.
|
|
